Additionally, SESN2 mediated the protective effects of exercise against dexamethasone‐ and immobilization‐induced muscle atrophy [19, 20], suggesting that SESN2 could be a promising therapeutic target for muscle atrophy. The gene discussed is SESN2; the disease is muscle atrophy.